Target diabetic Emerging continuous glucose monitoring system positions Arkal Medical as a potential supplier or partner for diabetes management solutions, creating opportunities to offer complementary devices, sensors, or integration services to clinics, hospitals, and pharmaceutical or device distributors.

Strategic partnerships Board-level expertise additions in the past and a focused product pipeline suggest openness to strategic alliances; explore collaboration with larger medical device manufacturers or distributors to scale manufacturing, regulatory approvals, and go-to-market reach.

SMB focus Small company size (2-10 employees) indicates agility but limited internal resources; sales efforts can emphasize rapid pilots, co-development opportunities, and turnkey deployment packages to reduce customer burden and accelerate adoption.

Tech stack fit Microsoft-based technology stack implies compatibility with enterprise IT environments; pitch integration capabilities with hospital information systems, EHRs, and cloud platforms to enable seamless data flow and monitoring workflows.

Funding signal Revenue in the reported range suggests a growing but early-stage business; identify early adopters and reference customers in the diabetes care continuum, plus phased procurement approaches and favorable terms to align with customer budgets.